Results 151 to 160 of about 90,608 (260)

Beyond CD4 counts: Multi‐biomarker assessment of estimated time since HIV‐1 infection and risk factors for late diagnosis

HIV Medicine, EarlyView.
Abstract Background Late diagnosis (LD) of HIV, defined as CD4 count <350 cells/μL or AIDS at diagnosis, remains a substantial public health challenge, with half of individuals in Europe diagnosed late. How long these individuals have lived with HIV remains unclear.
Kathleen Smith, Macauley Locke, Emmi Andersson, Sandra Broddesson, Christina Carlander, Aylin Yilmaz, Jan Albert, Thomas Leitner, Johanna Brännström   +8 more
wiley   +1 more source

A cross‐sectional analysis of cardiometabolic and lifestyle‐related profiles in men living with HIV in Japan using linked nationwide claims and health checkup data

HIV Medicine, EarlyView.
Abstract Objectives To compare objectively measured cardiometabolic health between people living with HIV (PLWH) and individuals without HIV using nationwide health checkup data linked to administrative claims, thereby partially mitigating surveillance bias associated with routine HIV care.
Kohei Yamashita, Kazuhiko Ikeuchi, Ryoko Sekiya, Yuki Arisato, Shinya Matsumoto, Toshiyuki Kishida, Akira Kado, Kazuya Okushin, Hiroshi Yotsuyanagi, Takeya Tsutsumi   +9 more
wiley   +1 more source

A systematic review of evidence on weight change following initiation of long‐acting cabotegravir for the prevention or treatment of HIV

HIV Medicine, EarlyView.
Abstract Background Weight gain is an increasingly recognized concern among people receiving antiretroviral therapy (ART) and may increase the risk of non‐communicable diseases. Integrase inhibitors (INSTIs) such as dolutegravir (DTG) have been associated with weight gain, but the metabolic effects of long‐acting cabotegravir (CAB‐LA), another INSTI ...
Jonathan Kitonsa, Ronald Komata, Wilber Ssembajjwe, Daniel Grint, Julian Robinson, Eugene Ruzagira, Robert Kalyesubula, Jaime Vera, Fiona Cresswell   +8 more
wiley   +1 more source

Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe: A cross‐sectional analysis of the HDV‐Europe cohort

HIV Medicine, EarlyView.
Abstract Introduction Infection with hepatitis D virus (HDV) is known to accelerate the progression of liver disease and is associated with mortality in individuals with HIV and hepatitis B virus (HBV). However, little is known about current HDV epidemiology, including HDV‐testing practices and prevalence, in this population in Europe.
Anders Boyd, Thomas Lutz, Kathrin van Bremen, Alessandro Tavelli, Antonella d'Arminio Monforte, Marc van der Valk, Miłosz Parczewski, Magdalena Tchorz, Iwona Cielniak, Luz Martín‐Carbonero, María del Mar Arcos‐Rueda, Charles Béguelin, Gilles Wandeler, Sanjay Bhagani, Charlotte Lim, Fauzi Elamouri, Juan Berenguer, Jürgen K. Rockstroh, Pablo Ryan   +18 more
wiley   +1 more source

Comparable anal HPV burden and abnormal cytology in MSM using PrEP and MSM living with HIV: implications for screening and prevention. [PDF]

Sex Transm Infect
Verheyden M, Surmont M, Goossens M, Mostmans Y, Kindt S, Brunetta JM, Sahebali S, Gutermuth J, Allard SD.   +8 more
europepmc   +1 more source

Chronic alanine aminotransferase elevation in people with HIV: Time trends over 22 years and genetic predisposition

HIV Medicine, EarlyView.
Abstract Introduction Chronic elevation of alanine aminotransferase (cALT) is common in people with HIV. Published reports on cALT prevalence time trends have not been uniform. It is unknown whether genetic background is associated with cALT in people with HIV. Methods cALT was defined as ALT levels (male, >50 U/L, female, >35 U/L) at ≥2 consecutive, 6‐
Noemi R. Simon, Carlotta Mondoka, Christian W. Thorball, Isabella C. Schoepf, Lene Ryom, Irene Abela, Charles Béguelin, Urs Führer, Helen Kovari, Catia Marzolini, Annalisa Marinosci, Christian Kahlert, Luigia Elzi, David Haerry, Matthias Cavassini, Bruno Ledergerber, Jacques Fellay, Gilles Wandeler, Philip E. Tarr, the Swiss HIV Cohort Study, IA Abela, K Aebi‐Popp, A Anagnostopoulos, E Bernasconi, A Boyd, DL Braun, HC Bucher, A Calmy, M Cavassini, SE Chaudron, A Ciuffi, G Dollenmaier, M Egger, L Elzi, JS Fehr, J Fellay, S Frigerio Malossa, CA Fux, HF Günthard, A Hachfeld, DHU Haerry, B Hasse, M Hoffmann, M Huber, D Jackson‐Perry, CR Kahlert, D Kaufmann, O Keiser, RD Kouyos, H Kovari, K Kusejko, ND Labhardt, K Leuzinger, C Marzolini, KJ Metzner, N Müller, J Nemeth, D Nicca, J Notter, P Paioni, M Perreau, A Rauch, LP Salazar‐Vizcaya, P Schmid, O Segeral, RF Speck, M Stöckle, B Surial, PE Tarr, A Trkola, G Wandeler, M Weisser, S. Yerly   +72 more
wiley   +1 more source

Feasibility and clinical outcomes of routine point‐of‐care screening for opportunistic infections among people with advanced HIV disease in Guyana

HIV Medicine, EarlyView.
Abstract Objectives We evaluated the feasibility and outcomes of implementing comprehensive Point‐of‐care (POC) opportunistic infections (OIs) screening among people with Advanced HIV disease (AHD) in Guyana. Methods We conducted a prospective multicentre cohort study across seven sites between February 2024 and March 2025.
Antonio Camiro‐Zúñiga, Tariq Jagnarine, Divya Shivdas, Lakshmi Narain, Kwesi Vanccoten, Kampta Prashad, Abiola Jacobs, Quacy Grant, Mallika Mootoo, Narissa Lawerence, Suzanne Siebs, Escalada Rainier, Omar Sued, Freddy Perez   +13 more
wiley   +1 more source

HIV pre-exposure prophylaxis in US prison settings: a model-based cost-effectiveness study. [PDF]

Lancet Reg Health Am
Park Y, Goldhaber-Fiebert JD, Cipriano LE.   +2 more
europepmc   +1 more source

Changes in cardiometabolic biomarkers 1 year after direct acting antiviral therapy for hepatitis C virus co‐infection among people with HIV

HIV Medicine, EarlyView.
Abstract Objectives Among people with HIV with hepatitis C virus (HCV) co‐infection, we examined differences in haemoglobin A1c (HbA1c), total cholesterol (TC), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD) risk score at 12‐months following direct acting antiviral (DAA) initiation ...
Raynell Lang, Elizabeth Humes, Asya Lyass, Leila H. Borowsky, Brenna Hogan, Arthur Y. Kim, Michael LaValley, Jennifer O. Lam, Ditipriya Bhar, Richard D. Moore, Frank Palella, Heidi Crane, Michael Horberg, Sonia Napravnik, Virginia A. Triant, Keri N. Althoff, on behalf of the North American AIDS Cohort Collaboration on Research and Design (NA‐ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)   +16 more
wiley   +1 more source

Master tracks in different resolutions of MARIA S. MERIAN cruise MSM-X19, Emden - Catania, 2024-11-18 - 2024-11-30

Raw data acquired by position sensors on board RV MERIAN during expedition MSM-X19 were processed to receive a validated master track which can be used as reference of further expedition data.
Wiemer, Gauvain
core   +1 more source